When did DENTSPLY SIRONA report Q4 2025 earnings?

DENTSPLY SIRONA (XRAY) reported Q4 2025 earnings on February 26, 2026 after market close.

What were DENTSPLY SIRONA's Q4 2025 revenue and EPS?

DENTSPLY SIRONA reported revenue of $961.0M and eps of $0.27 for Q4 2025.

Did DENTSPLY SIRONA beat estimates in Q4 2025?

Revenue beat the consensus estimate of $926.2M by $34.8M. EPS missed the consensus estimate of $0.28 by $0.01.

How did DENTSPLY SIRONA's Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 6.2% from $905.0M a year earlier and eps grew 3.8% from $0.26.

Where can I find DENTSPLY SIRONA's Q4 2025 SEC filings?

You can read the 8-K earnings release (0000818479-26-000058) and the 10-K periodic report (0000818479-26-000075) directly on SEC EDGAR. The filing index links above go to sec.gov.

DENTSPLY SIRONA XRAY Q4 2025 Annual earnings

Reported February 26, 2026 · After market close

Revenue$961.0MBeat by $34.8M

EPS$0.27Miss by $0.01

Revenue estimate$926.2M

EPS estimate$0.28

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$889.1M

EPS estimate$0.36

Financials

Q4 2025

Income statement

See full

Revenue$961.0M+6.2%

Gross profit$443.0M-0.7%

Operating income-$139.0M+72.7%

Net income-$146.0M+66.0%

EPS (diluted)-$0.73+65.7%

Balance sheet

See full

Cash & equivalents$326.0M+19.9%

Total debt$2.5B+8.6%

Total equity$1.3B-31.1%

Total assets$5.4B-5.6%

Cash flow

See full

Operating cash flow$101.0M+16.1%

CapEx$41.0M-19.6%

Free cash flow$60.0M+66.7%

Valuation & ratios

Valuation

as of 12/31/25

See full

Market cap$2.28B-39.5%

Enterprise value$4.42B-23.4%

P/S0.6×-0.4×

Profitability

See full

Gross margin50%-1.6pp

Operating margin-11.5%-3.8pp

Net margin-16.3%-4.0pp

FCF margin2.8%-4.6pp

Returns & leverage

See full

Return on equity-36.5%+1.9pp

Debt / equity1.8×+0.7×

Current ratio1.5×+0.4×

Segments

By segment

See full

Essential Dental Solutions$372.0M+7.5%

Connected Technology Solutions$299.0M+2.0%

Orthodontic and Implant Solutions$202.0M+9.2%

Wellspect Healthcare$88.0M+8.6%

By product

See full

Equipment & Instruments$160.0M+6.0%

Implants & Prosthetics$150.0M-7.4%

CAD/CAM$139.0M-2.1%

Orthodontics$52.0M+126%

Versus estimates

Revenue

Q1 2026$880.0MBeat by $38.2M

Q4 2025$961.0MBeat by $34.8M

Q3 2025$904.0MMiss by $23.1M Q2 2025$936.0MBeat by $31.4M Q1 2025$879.0MMiss by $41.2M Q4 2024$905.0MBeat by $3.7M

Diluted EPS

Q1 2026$0.27Miss by $0.01

Q4 2025$0.27Miss by $0.01

Q3 2025$0.37Miss by $0.08 Q2 2025$0.52Beat by $0.02 Q1 2025$0.43Beat by $0.14 Q4 2024$0.26Miss by $0.21

Ask the moment DENTSPLY SIRONA reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did DENTSPLY SIRONA report Q4 2025 earnings?: DENTSPLY SIRONA (XRAY) reported Q4 2025 earnings on February 26, 2026 after market close.
What were DENTSPLY SIRONA's Q4 2025 revenue and EPS?: DENTSPLY SIRONA reported revenue of $961.0M and eps of $0.27 for Q4 2025.
Did DENTSPLY SIRONA beat estimates in Q4 2025?: Revenue beat the consensus estimate of $926.2M by $34.8M. EPS missed the consensus estimate of $0.28 by $0.01.
How did DENTSPLY SIRONA's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 6.2% from $905.0M a year earlier and eps grew 3.8% from $0.26.
Where can I find DENTSPLY SIRONA's Q4 2025 SEC filings?: You can read the 8-K earnings release (0000818479-26-000058) and the 10-K periodic report (0000818479-26-000075) directly on SEC EDGAR. The filing index links above go to sec.gov.